Immune Health Supplements Market Size, Share & Trends Analysis Report By Product, By Form, By Application, By Mode Of Medication, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 2 Business Days
Immune Health Supplements Market Growth & Trends
The global immune health supplements market size was estimated at USD 52.81 billion in 2030 and is projected t%li%grow at a CAGR of 10.72% from 2024 t%li%2030. The growing prevalence of various infectious diseases caused by several micro-organisms, such as bacteria, fungi, viruses, and parasites, coupled with the rising demand for supplements t%li%increase the body's immune system, is expected t%li%boost the immune health supplements adoption across the globe. Besides, increasing adoption of immunity-boosting products due t%li%the COVID-19 pandemic is als%li%anticipated t%li%accelerate the market growth over the forecast years. According t%li%the Council for Responsible Nutrition (CRN) report in 2020, the consumption of dietary supplements among Americans was about 73 percent. However, taking dietary supplements among individuals for immune health has been increased from 27 percent t%li%32 percent from 2019 t%li%2020.
As of 2020, the vitamin and mineral supplements segment held the largest revenue share. The increasing adoption of vitamin C, D, multivitamins, and minerals resulted in a high revenue share for the segment in the market. An unhealthy diet limited physical activity, and a sedentary lifestyle are the key factors responsible for increasing vitamin and mineral intake t%li%improve an individual's immunity, especially in the developed regions such as North America and Europe. However, the increasing patient population and growing awareness for vitamin and mineral consumption are the major factors expected t%li%boost market growth in emerging economies such as Asia Pacific and Latin America during the forecast period. However, the herbal supplements segment is als%li%anticipated t%li%be the second-largest product segment due t%li%its popularity for long-term consumption as immunity boosters without any side effects.
By form, the tablets segment accounted for the largest revenue share in 2020. Due t%li%its longer shelf life and high preference of adoption among the individual's tablets segment is expected t%li%be the dominated segment. Tablets are more stable than the capsule, particularly in moist environments. In addition, tablets are largely manufactured by the key market players than the other form of supplements. Further, properties of tablets such as durability, inexpensive, can be split int%li%tw%li%parts, and higher dosage accommodation is anticipated its high adoption and maximum value share in the market.
The respiratory tract infection segment held the largest revenue share in 2020. Due t%li%the increasing prevalence of respiratory disorders such as COPD, asthma, COVID19, immune health supplements adoption has increased in the last couple of years. Particularly, the rapid rise in life-threatening coronavirus disease from the last year has increased the adoption of immunity-boosting products t%li%manage respiratory tract infections. Taking supplements such as Vitamin C, D, and minerals such as zinc and probiotics offers unique properties t%li%reduce the risk of respiratory tract infection, duration, and severity of infection.
As of 2020, the self-medication segment accounted for the largest revenue share than the prescription-based segment. It can be attributed due t%li%the high percentage of self-medicated supplements using the population around the globe. Further, most of the vitamins and mineral supplements d%li%not require a prescription. One can purchase them from pharmacies, groceries, and any convenience stores. Besides, the growing awareness among the individuals t%li%use immunity-boosting products due t%li%COVID19 is als%li%expected t%li%provide a high market share t%li%the self-medication segment over the forecast years globally.
The pharmacies/drug stores segment dominated the market and accounted for the largest revenue in 2020. The availability of a wide variety of products and the high preference of consumers t%li%buy immune health supplements from pharmacies are the factors responsible for the largest market share of this segment. Moreover, the availability of both prescriptions based and over-the-counter products for the consumers is als%li%expected t%li%accelerate the growth of the Pharmacies/drug stores segment over the forecast years.
North America dominated the market and accounted for the largest revenue share in 2020. The increasing prevalence of various health disorders, increasing usage of immune-enhancing products, and high spending capacity by the consumers are the factors anticipated t%li%provide the majority of market share t%li%the region. However, Asia Pacific countries, such as China, India, and Japan, are expected t%li%witness significant growth over the forecast years due t%li%the large population, increasing awareness, and growing consumer base in these countries.
Immune Health Supplements Market Report Highlights
Immune Health Supplements Market Growth & Trends
The global immune health supplements market size was estimated at USD 52.81 billion in 2030 and is projected t%li%grow at a CAGR of 10.72% from 2024 t%li%2030. The growing prevalence of various infectious diseases caused by several micro-organisms, such as bacteria, fungi, viruses, and parasites, coupled with the rising demand for supplements t%li%increase the body's immune system, is expected t%li%boost the immune health supplements adoption across the globe. Besides, increasing adoption of immunity-boosting products due t%li%the COVID-19 pandemic is als%li%anticipated t%li%accelerate the market growth over the forecast years. According t%li%the Council for Responsible Nutrition (CRN) report in 2020, the consumption of dietary supplements among Americans was about 73 percent. However, taking dietary supplements among individuals for immune health has been increased from 27 percent t%li%32 percent from 2019 t%li%2020.
As of 2020, the vitamin and mineral supplements segment held the largest revenue share. The increasing adoption of vitamin C, D, multivitamins, and minerals resulted in a high revenue share for the segment in the market. An unhealthy diet limited physical activity, and a sedentary lifestyle are the key factors responsible for increasing vitamin and mineral intake t%li%improve an individual's immunity, especially in the developed regions such as North America and Europe. However, the increasing patient population and growing awareness for vitamin and mineral consumption are the major factors expected t%li%boost market growth in emerging economies such as Asia Pacific and Latin America during the forecast period. However, the herbal supplements segment is als%li%anticipated t%li%be the second-largest product segment due t%li%its popularity for long-term consumption as immunity boosters without any side effects.
By form, the tablets segment accounted for the largest revenue share in 2020. Due t%li%its longer shelf life and high preference of adoption among the individual's tablets segment is expected t%li%be the dominated segment. Tablets are more stable than the capsule, particularly in moist environments. In addition, tablets are largely manufactured by the key market players than the other form of supplements. Further, properties of tablets such as durability, inexpensive, can be split int%li%tw%li%parts, and higher dosage accommodation is anticipated its high adoption and maximum value share in the market.
The respiratory tract infection segment held the largest revenue share in 2020. Due t%li%the increasing prevalence of respiratory disorders such as COPD, asthma, COVID19, immune health supplements adoption has increased in the last couple of years. Particularly, the rapid rise in life-threatening coronavirus disease from the last year has increased the adoption of immunity-boosting products t%li%manage respiratory tract infections. Taking supplements such as Vitamin C, D, and minerals such as zinc and probiotics offers unique properties t%li%reduce the risk of respiratory tract infection, duration, and severity of infection.
As of 2020, the self-medication segment accounted for the largest revenue share than the prescription-based segment. It can be attributed due t%li%the high percentage of self-medicated supplements using the population around the globe. Further, most of the vitamins and mineral supplements d%li%not require a prescription. One can purchase them from pharmacies, groceries, and any convenience stores. Besides, the growing awareness among the individuals t%li%use immunity-boosting products due t%li%COVID19 is als%li%expected t%li%provide a high market share t%li%the self-medication segment over the forecast years globally.
The pharmacies/drug stores segment dominated the market and accounted for the largest revenue in 2020. The availability of a wide variety of products and the high preference of consumers t%li%buy immune health supplements from pharmacies are the factors responsible for the largest market share of this segment. Moreover, the availability of both prescriptions based and over-the-counter products for the consumers is als%li%expected t%li%accelerate the growth of the Pharmacies/drug stores segment over the forecast years.
North America dominated the market and accounted for the largest revenue share in 2020. The increasing prevalence of various health disorders, increasing usage of immune-enhancing products, and high spending capacity by the consumers are the factors anticipated t%li%provide the majority of market share t%li%the region. However, Asia Pacific countries, such as China, India, and Japan, are expected t%li%witness significant growth over the forecast years due t%li%the large population, increasing awareness, and growing consumer base in these countries.
Immune Health Supplements Market Report Highlights
- The market is expected t%li%grow well over the forecast period owing t%li%the increasing prevalence of several infectious diseases and growing awareness t%li%improve immune health
- The vitamin and mineral supplements segment dominated the market in 2020 owing t%li%high demand and increasing use for immune health
- The respiratory tract infection application segment dominated the market in 2020 owing t%li%the increasing adoption of immune supplements t%li%reduce the risk of respiratory tract infection across the globe
- The self-medication segment dominated the market in 2020 majorly due t%li%a growing preference for self-medicated use of supplements than prescription-based
- The pharmacies/drug stores segment dominated the market in 2020 owing t%li%the availability of a wide range of products and high consumer preference
- North America dominated the market in 2020 majorly due t%li%high spending capacity and increasing uses of immune health supplements in the region
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Product Segment
1.2.2. Formulation Segment
1.2.3. Source Type Segment
1.2.4. Mode of Medication Segment
1.2.5. Distribution Channel Segment
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
CHAPTER 3. IMMUNE HEALTH SUPPLEMENTS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing health consciousness
3.2.1.2. Rising prevalence of chronic diseases
3.2.1.3. Growing geriatric population
3.2.2. Market restraint analysis
3.2.2.1. Stringent regulations
3.3. Immune Health Supplements Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
CHAPTER 4. IMMUNE HEALTH SUPPLEMENTS MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Product Segment Dashboard
4.2. Global Immune Health Supplements Market Product Movement Analysis
4.3. Global Immune Health Supplements Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Vitamin & Mineral Supplements
4.4.1. Vitamin & mineral supplements market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Vitamin C Supplements
4.4.2.1. Vitamin C supplements market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Vitamin D Supplements
4.4.3.1. Vitamin D supplements market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. Vitamin B Complex Supplements
4.4.4.1. Vitamin B complex supplements market estimates and forecasts 2018 to 2030 (USD Million)
4.4.5. Multivitamins
4.4.5.1. Multivitamins market estimates and forecasts 2018 to 2030 (USD Million)
4.4.6. Selenium Supplements
4.4.6.1. Selenium supplements market estimates and forecasts 2018 to 2030 (USD Million)
4.4.7. Zinc Supplements
4.4.7.1. Zinc supplements market estimates and forecasts 2018 to 2030 (USD Million)
4.4.8. Others
4.4.8.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Amino Acids
4.5.1. Amino acids market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Omega-3 Fatty Acids
4.6.1. Omega-3 fatty acids market estimates and forecasts 2018 to 2030 (USD Million)
4.7. Herbal Supplements
4.7.1. Herbal supplements market estimates and forecasts 2018 to 2030 (USD Million)
4.8. Probiotic Supplements
4.8.1. Probiotic supplements market estimates and forecasts 2018 to 2030 (USD Million)
4.9. Others
4.9.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. IMMUNE HEALTH SUPPLEMENTS MARKET: FORMULATION ESTIMATES & TREND ANALYSIS
5.1. Formulation Segment Dashboard
5.2. Global Immune Health Supplements Market Formulation Movement Analysis
5.3. Global Immune Health Supplements Market Size & Trend Analysis, by Formulation, 2018 to 2030 (USD Million)
5.4. Capsules
5.4.1. Capsules market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Tablets
5.5.1. Tablets market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Powder
5.6.1. Powder market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Liquid
5.7.1. Liquid market estimates and forecasts 2018 to 2030 (USD Million)
5.8. Softgels
5.8.1. Softgels market estimates and forecasts 2018 to 2030 (USD Million)
5.9. Others
5.9.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. IMMUNE HEALTH SUPPLEMENTS MARKET: SOURCE TYPE ESTIMATES & TREND ANALYSIS
6.1. Source Type Segment Dashboard
6.2. Global Immune Health Supplements Market Source Type Movement Analysis
6.3. Global Immune Health Supplements Market Size & Trend Analysis, by Source Type, 2018 to 2030 (USD Million)
6.4. Natural
6.4.1. Natural market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Synthetic
6.5.1. Synthetic market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 7. IMMUNE HEALTH SUPPLEMENTS MARKET: MODE OF MEDICATION ESTIMATES & TREND ANALYSIS
7.1. Mode of Medication Segment Dashboard
7.2. Global Immune Health Supplements Market Mode of Medication Movement Analysis
7.3. Global Immune Health Supplements Market Size & Trend Analysis, by Mode of Medication, 2018 to 2030 (USD Million)
7.4. Prescription-based
7.4.1. Prescription-based market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Self-medication
7.5.1. Self-medication market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 8. IMMUNE HEALTH SUPPLEMENTS MARKET: DISTRIBUTION CHANNEL ESTIMATES & TREND ANALYSIS
8.1. Distribution Channel Segment Dashboard
8.2. Global Immune Health Supplements Market Distribution Channel Movement Analysis
8.3. Global Immune Health Supplements Market Size & Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
8.4. Offline
8.4.1. Offline market estimates and forecasts 2018 to 2030 (USD Million)
8.4.2. Pharmacies & Drug Stores
8.4.2.1. Pharmacies & drug stores market estimates and forecasts 2018 to 2030 (USD Million)
8.4.3. Hypermarkets/Supermarkets
8.4.3.1. Hypermarkets/supermarkets market estimates and forecasts 2018 to 2030 (USD Million)
8.4.4. Others
8.4.4.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
8.5. Online
8.5.1. Online market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 9. IMMUNE HEALTH SUPPLEMENTS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS BY PRODUCT, FORMULATION, SOURCE TYPE, MODE OF MEDICATION, AND DISTRIBUTION CHANNEL
9.1. Regional Market Share Analysis, 2023 & 2030
9.2. Regional Market Dashboard
9.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
9.4. North America
9.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
9.4.2. U.S.
9.4.2.1. Key country dynamics
9.4.2.2. Regulatory framework
9.4.2.3. Competitive scenario
9.4.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
9.4.3. Canada
9.4.3.1. Key country dynamics
9.4.3.2. Regulatory framework
9.4.3.3. Competitive scenario
9.4.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
9.4.4. Mexico
9.4.4.1. Key country dynamics
9.4.4.2. Regulatory framework
9.4.4.3. Competitive scenario
9.4.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
9.5. Europe
9.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
9.5.2. UK
9.5.2.1. Key country dynamics
9.5.2.2. Regulatory framework
9.5.2.3. Competitive scenario
9.5.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
9.5.3. Germany
9.5.3.1. Key country dynamics
9.5.3.2. Regulatory framework
9.5.3.3. Competitive scenario
9.5.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
9.5.4. France
9.5.4.1. Key country dynamics
9.5.4.2. Regulatory framework
9.5.4.3. Competitive scenario
9.5.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
9.5.5. Italy
9.5.5.1. Key country dynamics
9.5.5.2. Regulatory framework
9.5.5.3. Competitive scenario
9.5.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
9.5.6. Spain
9.5.6.1. Key country dynamics
9.5.6.2. Regulatory framework
9.5.6.3. Competitive scenario
9.5.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
9.5.7. Norway
9.5.7.1. Key country dynamics
9.5.7.2. Regulatory framework
9.5.7.3. Competitive scenario
9.5.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
9.5.8. Sweden
9.5.8.1. Key country dynamics
9.5.8.2. Regulatory framework
9.5.8.3. Competitive scenario
9.5.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
9.5.9. Denmark
9.5.9.1. Key country dynamics
9.5.9.2. Regulatory framework
9.5.9.3. Competitive scenario
9.5.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
9.6. Asia Pacific
9.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
9.6.2. Japan
9.6.2.1. Key country dynamics
9.6.2.2. Regulatory framework
9.6.2.3. Competitive scenario
9.6.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
9.6.3. China
9.6.3.1. Key country dynamics
9.6.3.2. Regulatory framework
9.6.3.3. Competitive scenario
9.6.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
9.6.4. India
9.6.4.1. Key country dynamics
9.6.4.2. Regulatory framework
9.6.4.3. Competitive scenario
9.6.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
9.6.5. Australia
9.6.5.1. Key country dynamics
9.6.5.2. Regulatory framework
9.6.5.3. Competitive scenario
9.6.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
9.6.6. South Korea
9.6.6.1. Key country dynamics
9.6.6.2. Regulatory framework
9.6.6.3. Competitive scenario
9.6.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
9.6.7. Thailand
9.6.7.1. Key country dynamics
9.6.7.2. Regulatory framework
9.6.7.3. Competitive scenario
9.6.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
9.7. Latin America
9.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
9.7.2. Brazil
9.7.2.1. Key country dynamics
9.7.2.2. Regulatory framework
9.7.2.3. Competitive scenario
9.7.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
9.7.3. Argentina
9.7.3.1. Key country dynamics
9.7.3.2. Regulatory framework
9.7.3.3. Competitive scenario
9.7.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
9.8. MEA
9.8.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
9.8.2. South Africa
9.8.2.1. Key country dynamics
9.8.2.2. Regulatory framework
9.8.2.3. Competitive scenario
9.8.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
9.8.3. Saudi Arabia
9.8.3.1. Key country dynamics
9.8.3.2. Regulatory framework
9.8.3.3. Competitive scenario
9.8.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
9.8.4. UAE
9.8.4.1. Key country dynamics
9.8.4.2. Regulatory framework
9.8.4.3. Competitive scenario
9.8.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
9.8.5. Kuwait
9.8.5.1. Key country dynamics
9.8.5.2. Regulatory framework
9.8.5.3. Competitive scenario
9.8.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 10. COMPETITIVE LANDSCAPE
10.1. Company/Competition Categorization
10.2. Strategy Mapping
10.3. Company Market Position Analysis, 2023
10.4. Company Profiles/Listing
10.4.1. Nature's Way
10.4.1.1. Company overview
10.4.1.2. Financial performance
10.4.1.3. Product benchmarking
10.4.1.4. Strategic initiatives
10.4.2. NOW Foods
10.4.2.1. Company overview
10.4.2.2. Financial performance
10.4.2.3. Product benchmarking
10.4.2.4. Strategic initiatives
10.4.3. Garden of Life
10.4.3.1. Company overview
10.4.3.2. Financial performance
10.4.3.3. Product benchmarking
10.4.3.4. Strategic initiatives
10.4.4. Thorne Research
10.4.4.1. Company overview
10.4.4.2. Financial performance
10.4.4.3. Product benchmarking
10.4.4.4. Strategic initiatives
10.4.5. Nordic Naturals
10.4.5.1. Company overview
10.4.5.2. Financial performance
10.4.5.3. Product benchmarking
10.4.5.4. Strategic initiatives
10.4.6. Solaray
10.4.6.1. Company overview
10.4.6.2. Financial performance
10.4.6.3. Product benchmarking
10.4.6.4. Strategic initiatives
10.4.7. Pure Encapsulations
10.4.7.1. Company overview
10.4.7.2. Financial performance
10.4.7.3. Product benchmarking
10.4.7.4. Strategic initiatives
10.4.8. The Nature's Bounty Co.
10.4.8.1. Company overview
10.4.8.2. Financial performance
10.4.8.3. Product benchmarking
10.4.8.4. Strategic initiatives
10.4.9. MegaFood
10.4.9.1. Company overview
10.4.9.2. Financial performance
10.4.9.3. Product benchmarking
10.4.9.4. Strategic initiatives
10.4.10. Jarrow Formulas
10.4.10.1. Company overview
10.4.10.2. Financial performance
10.4.10.3. Product benchmarking
10.4.10.4. Strategic initiatives
10.4.11. Life Extension
10.4.11.1. Company overview
10.4.11.2. Financial performance
10.4.11.3. Product benchmarking
10.4.11.4. Strategic initiatives
10.4.12. Metagenics
10.4.12.1. Company overview
10.4.12.2. Financial performance
10.4.12.3. Product benchmarking
10.4.12.4. Strategic initiatives
10.4.13. Xymogen
10.4.13.1. Company overview
10.4.13.2. Financial performance
10.4.13.3. Product benchmarking
10.4.13.4. Strategic initiatives
10.4.14. Designs for Health
10.4.14.1. Company overview
10.4.14.2. Financial performance
10.4.14.3. Product benchmarking
10.4.14.4. Strategic initiatives
10.4.15. Douglas Laboratories
10.4.15.1. Company overview
10.4.15.2. Financial performance
10.4.15.3. Product benchmarking
10.4.15.4. Strategic initiatives
10.4.16. Bayer AG
10.4.16.1. Company overview
10.4.16.2. Financial performance
10.4.16.3. Product benchmarking
10.4.16.4. Strategic initiatives
10.4.17. Standard Process
10.4.17.1. Company overview
10.4.17.2. Financial performance
10.4.17.3. Product benchmarking
10.4.17.4. Strategic initiatives
10.4.18. Klaire Labs
10.4.18.1. Company overview
10.4.18.2. Financial performance
10.4.18.3. Product benchmarking
10.4.18.4. Strategic initiatives
10.4.19. Integrative Therapeutics
10.4.19.1. Company overview
10.4.19.2. Financial performance
10.4.19.3. Product benchmarking
10.4.19.4. Strategic initiatives
10.4.20. Amway, Co.
10.4.20.1. Company overview
10.4.20.2. Financial performance
10.4.20.3. Product benchmarking
10.4.20.4. Strategic initiatives
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Product Segment
1.2.2. Formulation Segment
1.2.3. Source Type Segment
1.2.4. Mode of Medication Segment
1.2.5. Distribution Channel Segment
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
CHAPTER 3. IMMUNE HEALTH SUPPLEMENTS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing health consciousness
3.2.1.2. Rising prevalence of chronic diseases
3.2.1.3. Growing geriatric population
3.2.2. Market restraint analysis
3.2.2.1. Stringent regulations
3.3. Immune Health Supplements Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
CHAPTER 4. IMMUNE HEALTH SUPPLEMENTS MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Product Segment Dashboard
4.2. Global Immune Health Supplements Market Product Movement Analysis
4.3. Global Immune Health Supplements Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Vitamin & Mineral Supplements
4.4.1. Vitamin & mineral supplements market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Vitamin C Supplements
4.4.2.1. Vitamin C supplements market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Vitamin D Supplements
4.4.3.1. Vitamin D supplements market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. Vitamin B Complex Supplements
4.4.4.1. Vitamin B complex supplements market estimates and forecasts 2018 to 2030 (USD Million)
4.4.5. Multivitamins
4.4.5.1. Multivitamins market estimates and forecasts 2018 to 2030 (USD Million)
4.4.6. Selenium Supplements
4.4.6.1. Selenium supplements market estimates and forecasts 2018 to 2030 (USD Million)
4.4.7. Zinc Supplements
4.4.7.1. Zinc supplements market estimates and forecasts 2018 to 2030 (USD Million)
4.4.8. Others
4.4.8.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Amino Acids
4.5.1. Amino acids market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Omega-3 Fatty Acids
4.6.1. Omega-3 fatty acids market estimates and forecasts 2018 to 2030 (USD Million)
4.7. Herbal Supplements
4.7.1. Herbal supplements market estimates and forecasts 2018 to 2030 (USD Million)
4.8. Probiotic Supplements
4.8.1. Probiotic supplements market estimates and forecasts 2018 to 2030 (USD Million)
4.9. Others
4.9.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. IMMUNE HEALTH SUPPLEMENTS MARKET: FORMULATION ESTIMATES & TREND ANALYSIS
5.1. Formulation Segment Dashboard
5.2. Global Immune Health Supplements Market Formulation Movement Analysis
5.3. Global Immune Health Supplements Market Size & Trend Analysis, by Formulation, 2018 to 2030 (USD Million)
5.4. Capsules
5.4.1. Capsules market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Tablets
5.5.1. Tablets market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Powder
5.6.1. Powder market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Liquid
5.7.1. Liquid market estimates and forecasts 2018 to 2030 (USD Million)
5.8. Softgels
5.8.1. Softgels market estimates and forecasts 2018 to 2030 (USD Million)
5.9. Others
5.9.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. IMMUNE HEALTH SUPPLEMENTS MARKET: SOURCE TYPE ESTIMATES & TREND ANALYSIS
6.1. Source Type Segment Dashboard
6.2. Global Immune Health Supplements Market Source Type Movement Analysis
6.3. Global Immune Health Supplements Market Size & Trend Analysis, by Source Type, 2018 to 2030 (USD Million)
6.4. Natural
6.4.1. Natural market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Synthetic
6.5.1. Synthetic market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 7. IMMUNE HEALTH SUPPLEMENTS MARKET: MODE OF MEDICATION ESTIMATES & TREND ANALYSIS
7.1. Mode of Medication Segment Dashboard
7.2. Global Immune Health Supplements Market Mode of Medication Movement Analysis
7.3. Global Immune Health Supplements Market Size & Trend Analysis, by Mode of Medication, 2018 to 2030 (USD Million)
7.4. Prescription-based
7.4.1. Prescription-based market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Self-medication
7.5.1. Self-medication market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 8. IMMUNE HEALTH SUPPLEMENTS MARKET: DISTRIBUTION CHANNEL ESTIMATES & TREND ANALYSIS
8.1. Distribution Channel Segment Dashboard
8.2. Global Immune Health Supplements Market Distribution Channel Movement Analysis
8.3. Global Immune Health Supplements Market Size & Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
8.4. Offline
8.4.1. Offline market estimates and forecasts 2018 to 2030 (USD Million)
8.4.2. Pharmacies & Drug Stores
8.4.2.1. Pharmacies & drug stores market estimates and forecasts 2018 to 2030 (USD Million)
8.4.3. Hypermarkets/Supermarkets
8.4.3.1. Hypermarkets/supermarkets market estimates and forecasts 2018 to 2030 (USD Million)
8.4.4. Others
8.4.4.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
8.5. Online
8.5.1. Online market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 9. IMMUNE HEALTH SUPPLEMENTS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS BY PRODUCT, FORMULATION, SOURCE TYPE, MODE OF MEDICATION, AND DISTRIBUTION CHANNEL
9.1. Regional Market Share Analysis, 2023 & 2030
9.2. Regional Market Dashboard
9.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
9.4. North America
9.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
9.4.2. U.S.
9.4.2.1. Key country dynamics
9.4.2.2. Regulatory framework
9.4.2.3. Competitive scenario
9.4.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
9.4.3. Canada
9.4.3.1. Key country dynamics
9.4.3.2. Regulatory framework
9.4.3.3. Competitive scenario
9.4.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
9.4.4. Mexico
9.4.4.1. Key country dynamics
9.4.4.2. Regulatory framework
9.4.4.3. Competitive scenario
9.4.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
9.5. Europe
9.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
9.5.2. UK
9.5.2.1. Key country dynamics
9.5.2.2. Regulatory framework
9.5.2.3. Competitive scenario
9.5.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
9.5.3. Germany
9.5.3.1. Key country dynamics
9.5.3.2. Regulatory framework
9.5.3.3. Competitive scenario
9.5.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
9.5.4. France
9.5.4.1. Key country dynamics
9.5.4.2. Regulatory framework
9.5.4.3. Competitive scenario
9.5.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
9.5.5. Italy
9.5.5.1. Key country dynamics
9.5.5.2. Regulatory framework
9.5.5.3. Competitive scenario
9.5.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
9.5.6. Spain
9.5.6.1. Key country dynamics
9.5.6.2. Regulatory framework
9.5.6.3. Competitive scenario
9.5.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
9.5.7. Norway
9.5.7.1. Key country dynamics
9.5.7.2. Regulatory framework
9.5.7.3. Competitive scenario
9.5.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
9.5.8. Sweden
9.5.8.1. Key country dynamics
9.5.8.2. Regulatory framework
9.5.8.3. Competitive scenario
9.5.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
9.5.9. Denmark
9.5.9.1. Key country dynamics
9.5.9.2. Regulatory framework
9.5.9.3. Competitive scenario
9.5.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
9.6. Asia Pacific
9.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
9.6.2. Japan
9.6.2.1. Key country dynamics
9.6.2.2. Regulatory framework
9.6.2.3. Competitive scenario
9.6.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
9.6.3. China
9.6.3.1. Key country dynamics
9.6.3.2. Regulatory framework
9.6.3.3. Competitive scenario
9.6.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
9.6.4. India
9.6.4.1. Key country dynamics
9.6.4.2. Regulatory framework
9.6.4.3. Competitive scenario
9.6.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
9.6.5. Australia
9.6.5.1. Key country dynamics
9.6.5.2. Regulatory framework
9.6.5.3. Competitive scenario
9.6.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
9.6.6. South Korea
9.6.6.1. Key country dynamics
9.6.6.2. Regulatory framework
9.6.6.3. Competitive scenario
9.6.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
9.6.7. Thailand
9.6.7.1. Key country dynamics
9.6.7.2. Regulatory framework
9.6.7.3. Competitive scenario
9.6.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
9.7. Latin America
9.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
9.7.2. Brazil
9.7.2.1. Key country dynamics
9.7.2.2. Regulatory framework
9.7.2.3. Competitive scenario
9.7.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
9.7.3. Argentina
9.7.3.1. Key country dynamics
9.7.3.2. Regulatory framework
9.7.3.3. Competitive scenario
9.7.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
9.8. MEA
9.8.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
9.8.2. South Africa
9.8.2.1. Key country dynamics
9.8.2.2. Regulatory framework
9.8.2.3. Competitive scenario
9.8.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
9.8.3. Saudi Arabia
9.8.3.1. Key country dynamics
9.8.3.2. Regulatory framework
9.8.3.3. Competitive scenario
9.8.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
9.8.4. UAE
9.8.4.1. Key country dynamics
9.8.4.2. Regulatory framework
9.8.4.3. Competitive scenario
9.8.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
9.8.5. Kuwait
9.8.5.1. Key country dynamics
9.8.5.2. Regulatory framework
9.8.5.3. Competitive scenario
9.8.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 10. COMPETITIVE LANDSCAPE
10.1. Company/Competition Categorization
10.2. Strategy Mapping
10.3. Company Market Position Analysis, 2023
10.4. Company Profiles/Listing
10.4.1. Nature's Way
10.4.1.1. Company overview
10.4.1.2. Financial performance
10.4.1.3. Product benchmarking
10.4.1.4. Strategic initiatives
10.4.2. NOW Foods
10.4.2.1. Company overview
10.4.2.2. Financial performance
10.4.2.3. Product benchmarking
10.4.2.4. Strategic initiatives
10.4.3. Garden of Life
10.4.3.1. Company overview
10.4.3.2. Financial performance
10.4.3.3. Product benchmarking
10.4.3.4. Strategic initiatives
10.4.4. Thorne Research
10.4.4.1. Company overview
10.4.4.2. Financial performance
10.4.4.3. Product benchmarking
10.4.4.4. Strategic initiatives
10.4.5. Nordic Naturals
10.4.5.1. Company overview
10.4.5.2. Financial performance
10.4.5.3. Product benchmarking
10.4.5.4. Strategic initiatives
10.4.6. Solaray
10.4.6.1. Company overview
10.4.6.2. Financial performance
10.4.6.3. Product benchmarking
10.4.6.4. Strategic initiatives
10.4.7. Pure Encapsulations
10.4.7.1. Company overview
10.4.7.2. Financial performance
10.4.7.3. Product benchmarking
10.4.7.4. Strategic initiatives
10.4.8. The Nature's Bounty Co.
10.4.8.1. Company overview
10.4.8.2. Financial performance
10.4.8.3. Product benchmarking
10.4.8.4. Strategic initiatives
10.4.9. MegaFood
10.4.9.1. Company overview
10.4.9.2. Financial performance
10.4.9.3. Product benchmarking
10.4.9.4. Strategic initiatives
10.4.10. Jarrow Formulas
10.4.10.1. Company overview
10.4.10.2. Financial performance
10.4.10.3. Product benchmarking
10.4.10.4. Strategic initiatives
10.4.11. Life Extension
10.4.11.1. Company overview
10.4.11.2. Financial performance
10.4.11.3. Product benchmarking
10.4.11.4. Strategic initiatives
10.4.12. Metagenics
10.4.12.1. Company overview
10.4.12.2. Financial performance
10.4.12.3. Product benchmarking
10.4.12.4. Strategic initiatives
10.4.13. Xymogen
10.4.13.1. Company overview
10.4.13.2. Financial performance
10.4.13.3. Product benchmarking
10.4.13.4. Strategic initiatives
10.4.14. Designs for Health
10.4.14.1. Company overview
10.4.14.2. Financial performance
10.4.14.3. Product benchmarking
10.4.14.4. Strategic initiatives
10.4.15. Douglas Laboratories
10.4.15.1. Company overview
10.4.15.2. Financial performance
10.4.15.3. Product benchmarking
10.4.15.4. Strategic initiatives
10.4.16. Bayer AG
10.4.16.1. Company overview
10.4.16.2. Financial performance
10.4.16.3. Product benchmarking
10.4.16.4. Strategic initiatives
10.4.17. Standard Process
10.4.17.1. Company overview
10.4.17.2. Financial performance
10.4.17.3. Product benchmarking
10.4.17.4. Strategic initiatives
10.4.18. Klaire Labs
10.4.18.1. Company overview
10.4.18.2. Financial performance
10.4.18.3. Product benchmarking
10.4.18.4. Strategic initiatives
10.4.19. Integrative Therapeutics
10.4.19.1. Company overview
10.4.19.2. Financial performance
10.4.19.3. Product benchmarking
10.4.19.4. Strategic initiatives
10.4.20. Amway, Co.
10.4.20.1. Company overview
10.4.20.2. Financial performance
10.4.20.3. Product benchmarking
10.4.20.4. Strategic initiatives
LIST OF TABLES
Table 1 List of abbreviation
Table 2 Global immune health supplements market, by region, 2018 - 2030 (USD Million)
Table 3 Global immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 4 Global immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 5 Global immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 6 Global immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 7 Global immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 8 North America immune health supplements market, by country, 2018 - 2030 (USD Million)
Table 9 North America immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 10 North America immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 11 North America immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 12 North America immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 13 North America immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 14 U.S. immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 15 U.S. immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 16 U.S. immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 17 U.S. immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 18 U.S. immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 19 Canada immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 20 Canada immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 21 Canada immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 22 Canada immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 23 Canada immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 24 Mexico immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 25 Mexico immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 26 Mexico immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 27 Mexico immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 28 Mexico immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 29 Europe immune health supplements market, by country, 2018 - 2030 (USD Million)
Table 30 Europe immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 31 Europe immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 32 Europe immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 33 Europe immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 34 Europe immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 35 Germany immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 36 Germany immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 37 Germany immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 38 Germany immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 39 Germany immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 40 UK immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 41 UK immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 42 UK immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 43 UK immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 44 UK immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 45 France immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 46 France immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 47 France immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 48 France immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 49 France immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 50 Italy immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 51 Italy immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 52 Italy immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 53 Italy immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 54 Italy immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 55 Spain immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 56 Spain immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 57 Spain immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 58 Spain immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 59 Spain immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 60 Denmark immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 61 Denmark immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 62 Denmark immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 63 Denmark immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 64 Denmark immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 65 Sweden immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 66 Sweden immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 67 Sweden immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 68 Sweden immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 69 Sweden immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 70 Norway immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 71 Norway immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 72 Norway immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 73 Norway immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 74 Norway immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 75 Asia Pacific immune health supplements market, by country, 2018 - 2030 (USD Million)
Table 76 Asia Pacific immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 77 Asia Pacific immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 78 Asia Pacific immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 79 Asia Pacific immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 80 Asia Pacific immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 81 China immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 82 China immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 83 China immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 84 China immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 85 China immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 86 Japan immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 87 Japan immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 88 Japan immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 89 Japan immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 90 Japan immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 91 India immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 92 India immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 93 India immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 94 India immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 95 India immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 96 South Korea immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 97 South Korea immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 98 South Korea immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 99 South Korea immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 100 South Korea immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 101 Australia immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 102 Australia immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 103 Australia immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 104 Australia immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 105 Australia immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 106 Thailand immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 107 Thailand immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 108 Thailand immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 109 Thailand immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 110 Thailand immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 111 Latin America immune health supplements market, by country, 2018 - 2030 (USD Million)
Table 112 Latin America immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 113 Latin America immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 114 Latin America immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 115 Latin America immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 116 Latin America immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 117 Brazil immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 118 Brazil immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 119 Brazil immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 120 Brazil immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 121 Brazil immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 122 Argentina immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 123 Argentina immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 124 Argentina immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 125 Argentina immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 126 Argentina immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 127 MEA immune health supplements market, by country, 2018 - 2030 (USD Million)
Table 128 MEA immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 129 MEA immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 130 MEA immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 131 MEA immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 132 MEA immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 133 South Africa immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 134 South Africa immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 135 South Africa immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 136 South Africa immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 137 South Africa immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 138 Saudi Arabia immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 139 Saudi Arabia immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 140 Saudi Arabia immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 141 Saudi Arabia immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 142 Saudi Arabia immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 143 UAE immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 144 UAE immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 145 UAE immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 146 UAE immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 147 UAE immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 148 Kuwait immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 149 Kuwait immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 150 Kuwait immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 151 Kuwait immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 152 Kuwait immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 1 List of abbreviation
Table 2 Global immune health supplements market, by region, 2018 - 2030 (USD Million)
Table 3 Global immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 4 Global immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 5 Global immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 6 Global immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 7 Global immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 8 North America immune health supplements market, by country, 2018 - 2030 (USD Million)
Table 9 North America immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 10 North America immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 11 North America immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 12 North America immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 13 North America immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 14 U.S. immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 15 U.S. immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 16 U.S. immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 17 U.S. immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 18 U.S. immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 19 Canada immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 20 Canada immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 21 Canada immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 22 Canada immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 23 Canada immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 24 Mexico immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 25 Mexico immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 26 Mexico immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 27 Mexico immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 28 Mexico immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 29 Europe immune health supplements market, by country, 2018 - 2030 (USD Million)
Table 30 Europe immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 31 Europe immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 32 Europe immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 33 Europe immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 34 Europe immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 35 Germany immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 36 Germany immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 37 Germany immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 38 Germany immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 39 Germany immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 40 UK immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 41 UK immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 42 UK immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 43 UK immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 44 UK immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 45 France immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 46 France immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 47 France immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 48 France immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 49 France immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 50 Italy immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 51 Italy immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 52 Italy immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 53 Italy immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 54 Italy immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 55 Spain immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 56 Spain immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 57 Spain immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 58 Spain immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 59 Spain immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 60 Denmark immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 61 Denmark immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 62 Denmark immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 63 Denmark immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 64 Denmark immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 65 Sweden immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 66 Sweden immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 67 Sweden immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 68 Sweden immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 69 Sweden immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 70 Norway immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 71 Norway immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 72 Norway immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 73 Norway immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 74 Norway immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 75 Asia Pacific immune health supplements market, by country, 2018 - 2030 (USD Million)
Table 76 Asia Pacific immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 77 Asia Pacific immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 78 Asia Pacific immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 79 Asia Pacific immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 80 Asia Pacific immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 81 China immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 82 China immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 83 China immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 84 China immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 85 China immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 86 Japan immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 87 Japan immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 88 Japan immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 89 Japan immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 90 Japan immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 91 India immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 92 India immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 93 India immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 94 India immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 95 India immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 96 South Korea immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 97 South Korea immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 98 South Korea immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 99 South Korea immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 100 South Korea immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 101 Australia immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 102 Australia immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 103 Australia immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 104 Australia immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 105 Australia immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 106 Thailand immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 107 Thailand immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 108 Thailand immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 109 Thailand immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 110 Thailand immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 111 Latin America immune health supplements market, by country, 2018 - 2030 (USD Million)
Table 112 Latin America immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 113 Latin America immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 114 Latin America immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 115 Latin America immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 116 Latin America immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 117 Brazil immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 118 Brazil immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 119 Brazil immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 120 Brazil immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 121 Brazil immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 122 Argentina immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 123 Argentina immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 124 Argentina immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 125 Argentina immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 126 Argentina immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 127 MEA immune health supplements market, by country, 2018 - 2030 (USD Million)
Table 128 MEA immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 129 MEA immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 130 MEA immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 131 MEA immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 132 MEA immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 133 South Africa immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 134 South Africa immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 135 South Africa immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 136 South Africa immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 137 South Africa immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 138 Saudi Arabia immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 139 Saudi Arabia immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 140 Saudi Arabia immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 141 Saudi Arabia immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 142 Saudi Arabia immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 143 UAE immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 144 UAE immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 145 UAE immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 146 UAE immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 147 UAE immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
Table 148 Kuwait immune health supplements market, by product, 2018 - 2030 (USD Million)
Table 149 Kuwait immune health supplements market, by formulation, 2018 - 2030 (USD Million)
Table 150 Kuwait immune health supplements market, by source type, 2018 - 2030 (USD Million)
Table 151 Kuwait immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
Table 152 Kuwait immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Pharma 4.0 Market: market outlook
Fig. 9 Cryostat competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Pharma 4.0 Market driver impact
Fig. 15 Pharma 4.0 Market restraint impact
Fig. 16 Pharma 4.0 Market strategic initiatives analysis
Fig. 17 Pharma 4.0 Market: Type movement analysis
Fig. 18 Pharma 4.0 Market: Type outlook and key takeaways
Fig. 19 Software market estimates and forecast, 2018 - 2030
Fig. 20 Services market estimates and forecast, 2018 - 2030
Fig. 21 Pharma 4.0 Market: Technology movement analysis
Fig. 22 Pharma 4.0 Market: Technology outlook and key takeaways
Fig. 23 AI & ML market estimates and forecast, 2018 - 2030
Fig. 24 Big data analytics market estimates and forecast, 2018 - 2030
Fig. 25 IoT market estimates and forecast, 2018 - 2030
Fig. 26 Block chain technology market estimates and forecast, 2018 - 2030
Fig. 27 Others market estimates and forecast, 2018 - 2030
Fig. 28 Pharma 4.0 Market: Application movement analysis
Fig. 29 Pharma 4.0 Market: Application outlook and key takeaways
Fig. 30 Drug Discovery & Development market estimates and forecast, 2018 - 2030
Fig. 31 Manufacturing market estimates and forecast, 2018 - 2030
Fig. 32 Supply Chain Management market estimates and forecast, 2018 - 2030
Fig. 33 Others market estimates and forecast, 2018 - 2030
Fig. 34 Pharma 4.0 Market: End Use movement analysis
Fig. 35 Pharma 4.0 Market: End Use outlook and key takeaways
Fig. 36 Pharma & Biotech companies market estimates and forecast, 2018 - 2030
Fig. 37 Healthcare providers market estimates and forecast, 2018 - 2030
Fig. 38 CRO & CDMO market estimates and forecast, 2018 - 2030
Fig. 39 Global Pharma 4.0 Market: Regional movement analysis
Fig. 40 Global Pharma 4.0 Market: Regional outlook and key takeaways
Fig. 41 Global Pharma 4.0 Market share and leading players
Fig. 42 North America market share and leading players
Fig. 43 Europe market share and leading players
Fig. 44 Asia Pacific market share and leading players
Fig. 45 Latin America market share and leading players
Fig. 46 Middle East & Africa market share and leading players
Fig. 47 North America: SWOT
Fig. 48 Europe SWOT
Fig. 49 Asia Pacific SWOT
Fig. 50 Latin America SWOT
Fig. 51 MEA SWOT
Fig. 52 North America, by country
Fig. 53 North America market estimates and forecasts, 2018 - 2030
Fig. 54 U.S. market estimates and forecasts, 2018 - 2030
Fig. 55 Canada market estimates and forecasts, 2018 - 2030
Fig. 56 Mexico market estimates and forecasts, 2018 - 2030
Fig. 57 Europe market estimates and forecasts, 2018 - 2030
Fig. 58 UK market estimates and forecasts, 2018 - 2030
Fig. 59 Germany market estimates and forecasts, 2018 - 2030
Fig. 60 France market estimates and forecasts, 2018 - 2030
Fig. 61 Italy market estimates and forecasts, 2018 - 2030
Fig. 62 Spain market estimates and forecasts, 2018 - 2030
Fig. 63 Denmark market estimates and forecasts, 2018 - 2030
Fig. 64 Sweden market estimates and forecasts, 2018 - 2030
Fig. 65 Norway market estimates and forecasts, 2018 - 2030
Fig. 66 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 67 China market estimates and forecasts, 2018 - 2030
Fig. 68 Japan market estimates and forecasts, 2018 - 2030
Fig. 69 India market estimates and forecasts, 2018 - 2030
Fig. 70 South Korea market estimates and forecasts, 2018 - 2030
Fig. 71 Australia market estimates and forecasts, 2018 - 2030
Fig. 72 Thailand market estimates and forecasts, 2018 - 2030
Fig. 73 Latin America market estimates and forecasts, 2018 - 2030
Fig. 74 Brazil market estimates and forecasts, 2018 - 2030
Fig. 75 Argentina market estimates and forecasts, 2018 - 2030
Fig. 76 Middle East and Africa market estimates and forecasts, 2018 - 2030
Fig. 77 South Africa market estimates and forecasts, 2018 - 2030
Fig. 78 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 79 UAE market estimates and forecasts, 2018 - 2030
Fig. 80 Kuwait market estimates and forecasts, 2018 - 2030
Fig. 81 Market share of key market players- Pharma 4.0 Market
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Pharma 4.0 Market: market outlook
Fig. 9 Cryostat competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Pharma 4.0 Market driver impact
Fig. 15 Pharma 4.0 Market restraint impact
Fig. 16 Pharma 4.0 Market strategic initiatives analysis
Fig. 17 Pharma 4.0 Market: Type movement analysis
Fig. 18 Pharma 4.0 Market: Type outlook and key takeaways
Fig. 19 Software market estimates and forecast, 2018 - 2030
Fig. 20 Services market estimates and forecast, 2018 - 2030
Fig. 21 Pharma 4.0 Market: Technology movement analysis
Fig. 22 Pharma 4.0 Market: Technology outlook and key takeaways
Fig. 23 AI & ML market estimates and forecast, 2018 - 2030
Fig. 24 Big data analytics market estimates and forecast, 2018 - 2030
Fig. 25 IoT market estimates and forecast, 2018 - 2030
Fig. 26 Block chain technology market estimates and forecast, 2018 - 2030
Fig. 27 Others market estimates and forecast, 2018 - 2030
Fig. 28 Pharma 4.0 Market: Application movement analysis
Fig. 29 Pharma 4.0 Market: Application outlook and key takeaways
Fig. 30 Drug Discovery & Development market estimates and forecast, 2018 - 2030
Fig. 31 Manufacturing market estimates and forecast, 2018 - 2030
Fig. 32 Supply Chain Management market estimates and forecast, 2018 - 2030
Fig. 33 Others market estimates and forecast, 2018 - 2030
Fig. 34 Pharma 4.0 Market: End Use movement analysis
Fig. 35 Pharma 4.0 Market: End Use outlook and key takeaways
Fig. 36 Pharma & Biotech companies market estimates and forecast, 2018 - 2030
Fig. 37 Healthcare providers market estimates and forecast, 2018 - 2030
Fig. 38 CRO & CDMO market estimates and forecast, 2018 - 2030
Fig. 39 Global Pharma 4.0 Market: Regional movement analysis
Fig. 40 Global Pharma 4.0 Market: Regional outlook and key takeaways
Fig. 41 Global Pharma 4.0 Market share and leading players
Fig. 42 North America market share and leading players
Fig. 43 Europe market share and leading players
Fig. 44 Asia Pacific market share and leading players
Fig. 45 Latin America market share and leading players
Fig. 46 Middle East & Africa market share and leading players
Fig. 47 North America: SWOT
Fig. 48 Europe SWOT
Fig. 49 Asia Pacific SWOT
Fig. 50 Latin America SWOT
Fig. 51 MEA SWOT
Fig. 52 North America, by country
Fig. 53 North America market estimates and forecasts, 2018 - 2030
Fig. 54 U.S. market estimates and forecasts, 2018 - 2030
Fig. 55 Canada market estimates and forecasts, 2018 - 2030
Fig. 56 Mexico market estimates and forecasts, 2018 - 2030
Fig. 57 Europe market estimates and forecasts, 2018 - 2030
Fig. 58 UK market estimates and forecasts, 2018 - 2030
Fig. 59 Germany market estimates and forecasts, 2018 - 2030
Fig. 60 France market estimates and forecasts, 2018 - 2030
Fig. 61 Italy market estimates and forecasts, 2018 - 2030
Fig. 62 Spain market estimates and forecasts, 2018 - 2030
Fig. 63 Denmark market estimates and forecasts, 2018 - 2030
Fig. 64 Sweden market estimates and forecasts, 2018 - 2030
Fig. 65 Norway market estimates and forecasts, 2018 - 2030
Fig. 66 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 67 China market estimates and forecasts, 2018 - 2030
Fig. 68 Japan market estimates and forecasts, 2018 - 2030
Fig. 69 India market estimates and forecasts, 2018 - 2030
Fig. 70 South Korea market estimates and forecasts, 2018 - 2030
Fig. 71 Australia market estimates and forecasts, 2018 - 2030
Fig. 72 Thailand market estimates and forecasts, 2018 - 2030
Fig. 73 Latin America market estimates and forecasts, 2018 - 2030
Fig. 74 Brazil market estimates and forecasts, 2018 - 2030
Fig. 75 Argentina market estimates and forecasts, 2018 - 2030
Fig. 76 Middle East and Africa market estimates and forecasts, 2018 - 2030
Fig. 77 South Africa market estimates and forecasts, 2018 - 2030
Fig. 78 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 79 UAE market estimates and forecasts, 2018 - 2030
Fig. 80 Kuwait market estimates and forecasts, 2018 - 2030
Fig. 81 Market share of key market players- Pharma 4.0 Market
